The MAHA Assessment’s Implications: Drugs (Part One)
FDA Law Blog
JUNE 4, 2025
There are also drugs the Assessment identifies as being used off-label without high-quality evidence or for uses that are approved but without rigorous true placebo-controlled trials (namely vaccines) and/or with known safety concerns. We will continue to monitor these developments as they come.
59 
Let's personalize your content